Combination treatment could minimise cancer relapse risk
25 March 2024
Data suggests that ribociclib plus endocrine therapy could provide a new treatment option more patients with HR-positive, HER2-negative early breast cancer.
25 March 2024
Construction of the largest genetics center in Russia has entered its second stage, with development underway on the premises of Sirius University. It is planned to create and equip more than 100 premises for laboratory research, including a center for preclinical research using laboratory animals and infrastructure for implementing projects in the field of paleogenetics.
In Russia, lutetium-177 is used to treat neuroendocrine tumors for the first time
22 March 2024
The Federal State Budgetary Institution Scientific Research Center for Radiology of the Ministry of Health of Russia has successfully utilized a Russian radiopharmaceutical drug based on lutetium-177 to treat patients with metastatic and inoperable neuroendocrine tumors for the first time. Both patients were diagnosed with a neuroendocrine tumor of the pancreas, progressing against the background of standard chemotherapy.
In 2023, Russia has registered 540 drugs
22 March 2024
In 2023, the Russian Ministry of Health registered a total of 540 medicines, with less than half, specifically 160 (29.6%), being of foreign origin. This was stated by the head of the department, Mikhail Murashko, emphasizing that “Russian pharma has begun to create innovative products.”
In Russia, regulatory requirements for the development of biotechnological drugs may be reduced
21 March 2024
Participants of the BRICS working group gathered in Mumbai, India, to delve into the study of competition in pharmaceutical markets. The discussion revolved around the proposal made by the Federal Antimonopoly Service (FAS) to revise regulatory requirements with the aim of boosting the competitiveness of new biosimilar drugs. As part of this discussion, the idea was also put forward to develop proposals to reduce barriers to access biological medicines in the BRICS markets and to create common regulatory instruments.
Parkinson’s infusion treatment demonstrates advantage over oral delivery
21 March 2024
Delivering the traditional Parkinson’s treatment via subcutaneous infusion over a 24-hour period was shown to be safe and effective, research found.
Mycoplasma testing market expected to value nearly $2 million by 2031 Technology innova
20 March 2024
Technology innovations and a stronger focus on developing novel drugs to treat chronic diseases, are key drivers for the global mycoplasma testing market up to the next decade, research states. According to research published by Coherent Market Insights, the global mycoplasma testing market is anticipated to reach $1,907.6 million by 2031.
By 2030, 150 new chemical enterprises will be created in Russia
20 March 2024
The Minister of Industry and Trade of the Russian Federation, Denis Manturov, announced during a meeting with President Vladimir Putin and members of the Cabinet of Ministers that approximately 150 new medium- and low-tonnage chemical enterprises will be established in Russia by 2030. Manturov stressed that, following the president’s orders, the development of the most crucial sectors for the economy is being shifted to the framework of national projects.
Innovative method could offer cost-effective sterilisation approach
19 March 2024
The new sterilisation method could provide an affordable, rapid approach for preparing microbiological culture media, research suggests.
In 2023, Russia has registered 540 drugs
19 March 2024
In 2023, the Russian Ministry of Health registered a total of 540 medicines, with less than half, specifically 160 (29.6%), being of foreign origin. This was stated by the head of the department, Mikhail Murashko, emphasizing that “Russian pharma has begun to create innovative products.”
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024
Microbial burden assessment of solid pharmaceutical products
22 April 2024
Seasonal variation of microbial contamination in pharmaceutical cleanrooms
22 April 2024